First human test: scientists check new Drug's safety in healthy volunteers
NCT ID NCT06387966
Summary
This was a first-in-human study to check the safety and how the body processes a new drug called flonoltinib maleate. It involved 40 healthy adult volunteers in China who received either a single dose of the drug or a placebo. The main goal was to see how safe the drug was and to measure its levels in the blood and urine over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEATHLY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chengdu Xinhua Hospital
Chengdu, Sichuan, 610000, China
Conditions
Explore the condition pages connected to this study.